Pfizer Inc. (PFE) Q4 2013 Earnings Results

Pfizer Beats on EPS, Stock Up 2.56%

Pfizer's earnings report shows a positive surprise in EPS, which likely contributed to the stock's increase of 2.56%. The company is focusing on innovation and maintaining its competitive edge, which may reassure investors about its future prospects. However, the lack of revenue data and guidance leaves some uncertainty.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$0.56	N/A	+6.46%

Management

Management commentary

Tone: Cautiously Optimistic

Overall, management expressed confidence in the company's strategic direction. They noted that they are focusing on innovation and maintaining market leadership.

Management highlighted strong performance in key product areas.

They emphasized ongoing investments in research and development.

Pfizer Beats on EPS, Stock Up 2.56%

Key numbers

Management commentary

Pfizer Inc.

More earnings this week

Pfizer Beats on EPS, Stock Up 2.56%

Key numbers

Management commentary